Investigating lymphatic signaling in scleroderma fibrosis
Lymphatic ERG signaling in scleroderma fibrosis
This study is looking at how certain signals in the lymphatic system might affect people with scleroderma, with the goal of finding new ways to improve treatments for this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11112303 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of lymphatic signaling in scleroderma, a condition characterized by autoimmune responses and fibrosis affecting multiple organs. The study aims to explore the molecular mechanisms behind the impairment of both blood and lymphatic systems in patients with scleroderma. By analyzing gene expression and signaling pathways, researchers hope to identify new therapeutic targets that could improve treatment options for this condition. The approach includes examining the role of specific transcription factors that may influence lymphatic regeneration and fibrosis.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with scleroderma who are experiencing symptoms related to vascular impairment.
Not a fit: Patients without a diagnosis of scleroderma or those with unrelated vascular conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that improve healing and reduce fibrosis in patients with scleroderma.
How similar studies have performed: While the specific focus on lymphatic signaling in scleroderma is relatively novel, there is growing evidence supporting the importance of vascular mechanisms in autoimmune diseases.
Where this research is happening
Boston, United States
- Boston University Medical Campus — Boston, United States (Active)
Researchers
- Principal investigator: Trojanowska, Maria — Boston University Medical Campus
- Study coordinator: Trojanowska, Maria
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.